Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
Active, not recruiting · NCT05838560 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders | Depressive Disorder, Treatment-Resistant, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, depressive disorder, mood disorder, premature aging syndrome, psychiatric disorder, schizophrenia | Active, not recruiting | Phase 2 | 2026-04-21 | NCT05838560 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UConn Health | 35 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University School of Medicine | St Louis | United States | 895 |